Mauna Kea Technologies Enters Licensing Talks for Cellvizio®

Mauna Kea Technologies announced it has entered exclusive negotiations for a licensing agreement for its Cellvizio® platform with a major industry player. This move is part of the company's strategic efforts to monetize its technological assets. Alongside this, the company is also involved in multiple licensing discussions across various therapeutic areas, indicating increasing interest in its technology.

The company is currently under safeguard proceedings, offering a structured framework to intensify discussions on financing options with long-term investors. This is intended to consolidate the company's financial position and support future growth. According to Sacha Loiseau, Chairman and CEO, these proceedings will help accelerate long-term partnerships.